|
A Matter of Definition |
Papers |
02/2009 |
Open2Net, Papers, 2009 |
|
A necessary evil |
Papers |
10/2005 |
Papers, The Marketer, 2005 |
|
Accept no substitute |
Papers |
02/2005 |
Papers, The Marketer, 2005 |
|
Achieving a market-led culture: A case study |
Papers |
08/2000 |
2000, Papers, Strategy making in medical markets |
|
Achieving Excellence in CRM |
Papers |
10/2002 |
Papers, Strategy across all industries, 2002 |
|
Across the Breadth |
Papers |
09/2009 |
Publications, Strategy making in medical markets, 2009 |
|
Against the Odds |
Papers |
01/2010 |
2010, Papers, Strategy making in medical markets |
|
Alcan Packaging |
Testimonials |
|
Testimonials |
|
Amersham Biosciences |
Testimonials |
|
Testimonials |
|
Ammunition for marketers |
Papers |
11/2003 |
Papers, The Marketer, 2003 |
|
An empirical investigation of marketing strategy quality in medical markets |
Papers |
02/2003 |
Papers, Strategy making in medical markets, 2003 |
|
An exploratory study of key opinion leadership management trends among European pharmaceutical companies |
Papers |
09/2009 |
Papers, Strategy making in medical markets, 2009 |
|
Are we getting it right? |
Papers |
07/2003 |
Papers, The Marketer, 2003 |
|
Are you worth the money? |
Papers |
09/2003 |
Papers, The Marketer, 2003 |
|
As chaves do marketing (in Portugese) |
Papers |
05/2006 |
Papers, Strategy across all industries, 2006 |
|
Ask the Oracle |
Papers |
08/2009 |
Publications, Strategy making in medical markets, 2009 |
|
Astellas Pharma International |
Testimonials |
|
Testimonials |
|
AstraZeneca |
Testimonials |
|
Testimonials |